Top 5 Stocks to Buy Now
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

Compare

OCEAW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Ocean Biomedical stock or one of its competitors? MarketBeat compares Ocean Biomedical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ocean Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Ocean Biomedical compare to Ainos?

Ocean Biomedical (NASDAQ:OCEAW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Ainos beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Alvotech?

Ocean Biomedical (NASDAQ:OCEAW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Alvotech Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Alvotech beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Aravive?

Aravive (NASDAQ:ARAV) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Ocean Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Ocean Biomedical Neutral

Summary

Aravive beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

How does Ocean Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Ocean Biomedical (NASDAQ:OCEAW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Ocean Biomedical and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Ocean Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Ocean Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Summary

Biofrontera beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$381.56M$6.43B$12.59B
Dividend YieldN/A3.86%2.68%5.81%
P/E RatioN/A3.1224.7524.42
Price / SalesN/A6,861.77529.99108.89
Price / CashN/A13.1345.0755.09
Price / BookN/A92.2610.806.58
Net IncomeN/A-$96.07M$3.57B$337.17M

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/AN/AN/AN/A$0.00N/AN/A2
AIMDW
Ainos
N/A$0.49
+273.8%		N/A-48.8%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.27
-9.0%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel